Cargando…

Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy

Cyclic dinucleotides (CDNs) as stimulator of interferon genes (STING) agonists capable of inducing strong antitumor innate immune response are highly promising for tumor immunotherapy. The efficacy of these CDNs is, however, reduced greatly by their fast clearance, poor cell uptake and inefficient c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Huan, Guo, Beibei, Qiu, Xinyun, Xia, Yifeng, Qu, Yan, Cheng, Liang, Meng, Fenghua, Zhong, Zhiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958419/ https://www.ncbi.nlm.nih.gov/pubmed/35386324 http://dx.doi.org/10.1016/j.bioactmat.2022.02.029

Ejemplares similares

Endosomolytic Polymersomes Increase the Activity of Cyclic Dinucleotide STING Agonists to Enhance Cancer Immunotherapy
por: Shae, Daniel, et al.
Publicado: (2019)

STING cyclic dinucleotide sensing originated in bacteria
por: Morehouse, Benjamin R., et al.
Publicado: (2020)

Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin
por: Zou, Yan, et al.
Publicado: (2018)

STING inhibitors target the cyclic dinucleotide binding pocket
por: Hong, Ze, et al.
Publicado: (2021)

Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists
por: Vavřina, Zdeněk, et al.
Publicado: (2022)

Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant
por: Wei, Jingjing, et al.
Publicado: (2022)

Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy
por: Sun, Xiaoqi, et al.
Publicado: (2021)

Tumor-targeted delivery of a STING agonist improves cancer immunotherapy
por: Wu, You-tong, et al.
Publicado: (2022)

Biodegradable Polymersomes with Structure Inherent Fluorescence and Targeting Capacity for Enhanced Photo‐Dynamic Therapy
por: Cao, Shoupeng, et al.
Publicado: (2021)

Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic Dinucleotides
por: Yi, Guanghui, et al.
Publicado: (2013)

A STING-based fluorescent polarization assay for monitoring activities of cyclic dinucleotide metabolizing enzymes
por: Karanja, Caroline W., et al.
Publicado: (2020)

Bacterial Cyclic Dinucleotides and the cGAS–cGAMP–STING Pathway: A Role in Periodontitis?
por: Elmanfi, Samira, et al.
Publicado: (2021)

A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis
por: Dey, Bappaditya, et al.
Publicado: (2015)

Structure of STING bound to c-di-GMP Reveals the Mechanism of Cyclic Dinucleotide Recognition by the Immune System
por: Shu, Chang, et al.
Publicado: (2012)

Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
por: Leong, Meredith, et al.
Publicado: (2013)

Selective Loss of Responsiveness to Exogenous but Not Endogenous Cyclic-Dinucleotides in Mice Expressing STING-R231H
por: Walker, Melissa M., et al.
Publicado: (2020)

Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein
por: Smola, Miroslav, et al.
Publicado: (2021)

Cyclic dinucleotides (CDNs) reversed T cells tolerance in anti-tumor immunotherapy
por: Fu, Juan, et al.
Publicado: (2015)

Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor
por: Zou, Yan, et al.
Publicado: (2019)

Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy
por: Zhou, Ying, et al.
Publicado: (2022)

Cyclic dinucleotides mediate bacterial immunity by dinucleotide cyclase in Vibrio
por: Lu, Zengzeng, et al.
Publicado: (2022)

A STING-based biosensor affords broad cyclic dinucleotide detection within single living eukaryotic cells
por: Pollock, Alex J., et al.
Publicado: (2020)

Enzymatic synthesis of cyclic dinucleotide analogs by a promiscuous cyclic-AMP-GMP synthetase and analysis of cyclic dinucleotide responsive riboswitches
por: Launer-Felty, Katherine D, et al.
Publicado: (2018)

Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity
por: Corrales, Leticia, et al.
Publicado: (2014)

The Age of Cyclic Dinucleotide Vaccine Adjuvants
por: Gogoi, Himanshu, et al.
Publicado: (2020)

The World of Cyclic Dinucleotides in Bacterial Behavior
por: Aline Dias da, Purificação, et al.
Publicado: (2020)

Supramolecular polymer formation by cyclic dinucleotides and intercalators affects dinucleotide enzymatic processing
por: Nakayama, Shizuka, et al.
Publicado: (2016)

Highly Efficient Preparation of Cyclic Dinucleotides via Engineering of Dinucleotide Cyclases in Escherichia coli
por: Lv, Yun, et al.
Publicado: (2019)

Cyclic Dinucleotides in Oral Bacteria and in Oral Biofilms
por: Gürsoy, Ulvi K., et al.
Publicado: (2017)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy
por: Go, Eun-Jin, et al.
Publicado: (2020)

Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy
por: Wang, Bin, et al.
Publicado: (2022)

Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
por: Huang, Cuiqing, et al.
Publicado: (2023)

Activation of Gingival Fibroblasts by Bacterial Cyclic Dinucleotides and Lipopolysaccharide
por: Elmanfi, Samira, et al.
Publicado: (2020)

Mass spectrometric characterization of cyclic dinucleotides (CDNs) in vivo
por: Annibal, Andrea, et al.
Publicado: (2021)

Biodegradable Polymersomes for the Delivery of Gemcitabine to Panc-1 Cells
por: Sood, Nimil, et al.
Publicado: (2013)

Light-Triggered Polymersome-Based Anticancer Therapeutics Delivery
por: Hernández Becerra, Elisa, et al.
Publicado: (2022)

Redox-Responsive Polymersomes as Smart Doxorubicin Delivery Systems
por: Ferrero, Carmen, et al.
Publicado: (2022)

Polymersome-based protein drug delivery – quo vadis?
por: Gouveia, Micael G., et al.
Publicado: (2022)

Investigating cyclic nucleotide and cyclic dinucleotide binding to HCN channels by surface plasmon resonance
por: Hayoz, Sebastien, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1p33k2jeqg416t9dkg587de2p4